PHARM ACO KIN ETICS, SAFETY, AND TOLERABILITY OF UPADACITINIB IN CHILDREN WITH ATOPIC DERMATITIS

Authors
Category Primary study
ConferenceClinical Pharmacology and Therapeutics
Year 2023
This article has no abstract
Epistemonikos ID: 9a890327d9066062eb8c0d77f9e9a8cbd887e723
First added on: Apr 30, 2026